THE PERVASIVELY REGULATED BUSINESS EXCEPTION AND THE FDA

DSpace/Manakin Repository

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Wood, Valerie D.	en_US
dc.date.accessioned	2012-06-15T20:17:40Z
dc.date.issued	1995	en_US
dc.identifier.citation	THE PERVASIVELY REGULATED BUSINESS EXCEPTION AND THE FDA (1995 Third Year Paper)	en
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8889438
dc.description.abstract	Section 704 of the Federal Food, Drug and Cosmetic Act authorizes the Food and Drug Administration to conduct inspections of regulated business establishments. In the statute. Congress required that the inspections be at reasonable times and within reasonable limits and in a reasonable manner. Congress further restricted the inspections from including general financial and personnel data, and research data not relating to specially regulated drugs.	en
dc.language.iso	en_US	en
dash.license	LAA	en_US
dc.subject	Food and Drug Law	en
dc.subject	warrant	en
dc.subject	search and seizure	en
dc.subject	drug regulation	en
dc.title	THE PERVASIVELY REGULATED BUSINESS EXCEPTION AND THE FDA	en
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-06-15T20:17:40Z